Spectral Ai Inc (MDAI) Stock Price, Quote & News

Company Profile

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation; and delivers a binary prediction on the wounds capacity to heal or not heal by a specified time point in the future to assist the...

Industry: Medical Devices

Sector: Healthcare

Phone: 972 499 4934

Website: www.spectral-ai.com

Address:

2515 McKinney Avenue, Suite 1000, Dallas, United States

AptRutabaga Apr. 24 at 8:01 PM

$MDAI this was one of the terms in the terms of Vincent Capone's official CEO offer letter filed 4/22/26: "e. Exit Bonus. The Company anticipates that its Board of Directors will approve, as soon as reasonably practicable, an executive team exit bonus plan in which you and select other executives will participate in that will be structured to reward the executive team in the event of the consummation of the sale of the Company. This bonus plan will be in lieu of any “pay to stay” or similar arrangements." As of right now, I don't think there's a way of knowing what the compensation looks like, but it's good to see alignment among the executives and shareholders...

1 · Reply

AptRutabaga Apr. 24 at 7:30 PM

$MDAI do we think we’re forming a similar consolidation pattern to the last FDA runup last July?

4 · Reply

Medicalstocks Apr. 24 at 6:39 PM

$MDAI im addicted to watching the price action on this…… this much static hasn't happend in two years…

0 · Reply

Jimzi1 Apr. 24 at 6:09 PM

$MDAI news up indeed. Love your following . HTF did you manage to get a negative following- well done

0 · Reply

DisneyPalaceTrades Apr. 24 at 4:12 PM

$MDAI news up?

0 · Reply

Medicalstocks Apr. 23 at 8:39 PM

$MDAI pretty grand day today!!

0 · Reply

KTGAMBLESTOCKS Apr. 23 at 7:20 PM

$MDAI added 1.73 this morning

1 · Reply

Snellejelle Apr. 23 at 6:42 PM

$MDAI Holding up very Well against the storm of the rest

0 · Reply

TheBroker4 Apr. 23 at 3:09 PM

$MDAI That big red candle this morning triggered my buy order for another 2,500 shares.

1 · Reply

cryptobythelake Apr. 23 at 2:28 PM

$MDAI Who Issues the News Release? It is almost always the manufacturer, not the FDA, that issues a news release immediately upon receiving clearance. Yahoo Finance Company Control: Once the manufacturer receives the official clearance letter, they are legally allowed to market the device and typically coordinate their own press releases to inform investors and the public. Market Sensitivity: Publicly traded companies are often bound by SEC rules (such as Regulation FD) to disclose material information like a new clearance to the public as soon as possible. U.S. Food and Drug Administration (.gov) Key Exceptions The FDA is more likely to issue its own news release for: devices that are the first of their kind. Emergency Use Authorizations (EUA): Devices cleared during public health emergencies (e.g., new diagnostic tests during a pandemic). Breakthrough Devices: Novel technologies that provide significant advantages over existing treatments. U.S. Food and Drug Administration (.gov)

2 · Reply

Spectral AI's DeepView® System Showcased at 2026 American Burn Association Annual Meeting

Apr 20, 2026, 4:15 PM EDT - 5 days ago

Spectral AI Announces Annual Meeting of Stockholders

Apr 9, 2026, 8:30 AM EDT - 16 days ago

Spectral AI to Feature DeepView® System at 2026 American Burn Association Annual Meeting

Apr 8, 2026, 8:30 AM EDT - 17 days ago

Spectral AI Names David McGuire, CPA, as Chief Financial Officer

Mar 24, 2026, 5:00 PM EDT - 4 weeks ago

Spectral AI Earnings Call Transcript: Q4 2025

Mar 24, 2026, 4:25 PM EDT - 4 weeks ago

Spectral AI Announces 2025 Fourth Quarter and Full Year Financial Results and Introduces Revenue Guidance for 2026

Mar 19, 2026, 11:30 AM EDT - 5 weeks ago

Spectral AI Stock Jumps After $31.7 Million Funding Award

Mar 18, 2026, 4:05 PM EDT - 5 weeks ago

Spectral AI Awarded $31.7 Million of BARDA Funding to Accelerate Development of the DeepView® System

Mar 10, 2026, 8:30 AM EDT - 6 weeks ago

Spectral AI Schedules 2025 Fourth Quarter and Full Year Financial Results and Conference Call

Feb 10, 2026, 8:30 AM EST - 2 months ago

Spectral AI Names Vincent S. Capone as Chief Executive Officer

Feb 2, 2026, 8:30 AM EST - 2 months ago

Spectral AI to Participate in National Burn Awareness Week 2026 February 1–7, 2026

Nov 19, 2025, 8:00 AM EST - 5 months ago

DeepView™ System Featured at 2025 US Burn Conferences

Nov 11, 2025, 5:00 PM EST - 5 months ago

Spectral AI Earnings Call Transcript: Q3 2025

Nov 11, 2025, 4:00 PM EST - 5 months ago

Spectral AI Announces 2025 Third Quarter Financial Results

Oct 28, 2025, 4:00 PM EDT - 6 months ago

Spectral AI Schedules 2025 Third Quarter Financial Results and Conference Call

Oct 23, 2025, 8:30 AM EDT - 6 months ago

Spectral AI raises $7.6 Million of Additional Growth Capital

Sep 19, 2025, 8:00 AM EDT - 7 months ago

Spectral AI Named to TIME's List of World's Top HealthTech Companies 2025

Sep 10, 2025, 8:00 AM EDT - 8 months ago

DeepView® System highlighted at the European Burns Association Congress

Aug 12, 2025, 5:00 PM EDT - 9 months ago

Spectral AI Earnings Call Transcript: Q2 2025

Aug 12, 2025, 4:00 PM EDT - 9 months ago

Spectral AI Announces 2025 Second Quarter Financial Results

Jul 30, 2025, 8:00 AM EDT - 9 months ago

Spectral AI Schedules 2025 Second Quarter Financial Results and Conference Call

Jun 30, 2025, 8:00 AM EDT - 10 months ago

Spectral AI Announces Submission to FDA of its DeepView® System

Jun 10, 2025, 8:00 AM EDT - 11 months ago

DeepView® System highlighted at the annual British Burn Association conference

May 30, 2025, 8:00 AM EDT - 11 months ago

Spectral AI Announces Appointment of Stanley Micek as Chief Operating Officer

May 29, 2025, 8:00 AM EDT - 11 months ago

Spectral AI Announces Voting Results from 2025 Annual Meeting of Stockholders

May 13, 2025, 5:00 PM EDT - 1 year ago

Spectral AI Earnings Call Transcript: Q1 2025

May 13, 2025, 4:05 PM EDT - 1 year ago

Spectral AI Announces 2025 First Quarter Financial Results

Apr 30, 2025, 4:00 PM EDT - 1 year ago

Burn clinicians present positive findings of the DeepView® System's accuracy at the American Burn Association annual meeting

Mar 27, 2025, 5:00 PM EDT - 1 year ago

Spectral AI Earnings Call Transcript: Q4 2024

Mar 27, 2025, 4:55 PM EDT - 1 year ago

Spectral AI Announces 2024 Fourth Quarter and Full Year Financial Results

Mar 24, 2025, 7:30 AM EDT - 1 year ago

Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization

Mar 20, 2025, 4:00 PM EDT - 1 year ago

Spectral AI Announces Public Filing of Registration Statement for Proposed Initial Public Offering of Spectral IP

Mar 17, 2025, 7:00 AM EDT - 1 year ago

Spectral AI Announces Successful Results from its Burn Validation Study of the DeepView System

Mar 6, 2025, 10:36 AM EST - 1 year ago

Spectral AI Completes Three Device Installations in Australia

Feb 28, 2025, 10:34 AM EST - 1 year ago

CORRECTION: Spectral AI Schedules 2024 Fourth Quarter and Full Year Financial Results and Conference Call

Feb 7, 2025, 8:21 AM EST - 1 year ago

Spectral AI Completes Data Analysis for U.S. Burn Pivotal Study

Jan 28, 2025, 9:44 AM EST - 1 year ago

Spectral AI Completes Pediatric Enrollment in Emergency Departments for U.S. Burn Pivotal Study

Jan 22, 2025, 8:00 AM EST - 1 year ago

Spectral AI Provides Update to Investors

Dec 31, 2024, 8:00 AM EST - 1 year ago

Spectral AI Provides Instructions for Retail Investors on Exercising Publicly-Traded Warrants

Dec 23, 2024, 8:00 AM EST - 1 year ago

Spectral AI Announces Confirmation of Compliance of its Nasdaq Listing Requirements

Dec 13, 2024, 11:53 AM EST - 1 year ago

Spectral AI Comments on Compliance with Nasdaq Listing Rule 5550(b)(2)

Dec 9, 2024, 8:00 AM EST - 1 year ago

Spectral AI Incorporates Frontline Feedback into Improved Software Release for Enhanced Diagnostic Precision

Dec 2, 2024, 8:39 AM EST - 1 year ago

Spectral AI Completes Truthing of Burn Center Images, Initiates Emergency Department Image Review

Nov 26, 2024, 10:17 AM EST - 1 year ago

Spectral AI Announces Repricing of its Public Warrants

Nov 19, 2024, 8:00 AM EST - 1 year ago

Spectral AI Raises Up to $5 Million Financing Strengthening Financial Position for FDA Pathway

Nov 6, 2024, 5:00 PM EST - 1 year ago

Spectral AI Earnings Call Transcript: Q3 2024

Nov 6, 2024, 4:05 PM EST - 1 year ago

Spectral AI Announces 2024 Third Quarter Financial Results

Nov 6, 2024, 8:00 AM EST - 1 year ago

Spectral AI Announces Plan to Spin Off Spectral IP Subsidiary Focused on Intellectual Property Investments and Monetization

Oct 23, 2024, 4:50 PM EDT - 1 year ago

Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call

Oct 23, 2024, 4:01 AM EDT - 1 year ago

AI in Wound Care Market Industry Research Report 2024-2035 Featuring Key Players - eKare, healthy.io, Kronikare, Intellicure, Perceptive Solutions, Spectral AI, Swift Medical, Wound Pros Among Others

Oct 14, 2024, 4:05 PM EDT - 1 year ago

Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors

Oct 3, 2024, 8:00 AM EDT - 1 year ago

Spectral AI Completes Proof of Concept for Wound Measurement Technology

Sep 24, 2024, 8:00 AM EDT - 1 year ago

Spectral AI Achieves 25% Patient Enrollment at Emergency Departments for U.S. Burn Pivotal Study and Adds Two New Clinical Trial Sites

Sep 17, 2024, 8:00 AM EDT - 1 year ago

Spectral AI Outlines U.S. Regulatory Pathway for DeepView® System for Burn Indication

Sep 10, 2024, 8:00 AM EDT - 1 year ago

American Burn Association Study Highlights Inequities in Access to Specialized Burn Care

Sep 9, 2024, 7:00 AM EDT - 1 year ago

Spectral AI Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 5, 2024, 8:00 AM EDT - 1 year ago

Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium to Support Ongoing Development of DeepView SnapShot M®

Aug 12, 2024, 5:00 PM EDT - 1 year ago

Spectral AI Earnings Call Transcript: Q2 2024

May 9, 2024, 12:15 PM EDT - 2 years ago

Spectral AI Transcript: Sidoti Micro-Cap Virtual Investor Conference

May 7, 2024, 5:00 PM EDT - 2 years ago

Spectral AI Earnings Call Transcript: Q1 2024

Mar 27, 2024, 5:00 PM EDT - 2 years ago

Spectral AI Earnings Call Transcript: Q4 2023

Nov 14, 2023, 9:00 AM EST - 2 years ago

Spectral AI Earnings Call Transcript: Q3 2023

AptRutabaga Apr. 24 at 8:01 PM

1 · Reply

AptRutabaga Apr. 24 at 7:30 PM

$MDAI do we think we’re forming a similar consolidation pattern to the last FDA runup last July?

4 · Reply

Medicalstocks Apr. 24 at 6:39 PM

$MDAI im addicted to watching the price action on this…… this much static hasn't happend in two years…

0 · Reply

Jimzi1 Apr. 24 at 6:09 PM

$MDAI news up indeed. Love your following . HTF did you manage to get a negative following- well done

0 · Reply

DisneyPalaceTrades Apr. 24 at 4:12 PM

$MDAI news up?

0 · Reply

Medicalstocks Apr. 23 at 8:39 PM

$MDAI pretty grand day today!!

0 · Reply

KTGAMBLESTOCKS Apr. 23 at 7:20 PM

$MDAI added 1.73 this morning

1 · Reply

Snellejelle Apr. 23 at 6:42 PM

$MDAI Holding up very Well against the storm of the rest

0 · Reply

TheBroker4 Apr. 23 at 3:09 PM

$MDAI That big red candle this morning triggered my buy order for another 2,500 shares.

1 · Reply

cryptobythelake Apr. 23 at 2:28 PM

2 · Reply

cryptobythelake Apr. 23 at 2:25 PM

$MDAI Exactly and the odds that SAI would sit on the news days or weeks before a meeting are slim and none; and we all know who left town.

0 · Reply

Milli80 Apr. 23 at 1:35 PM

$MDAI damn shawty…

0 · Reply

MetroStockTrader Apr. 23 at 11:53 AM

$MDAI The FDA announces approvals/rejections publicly on their website. They no longer provide the information privately so the company can make the announcement.

1 · Reply

afterhoursearnings Apr. 23 at 12:08 AM

$MDAI eh, take a look at the volume on the last run up to 3, imo it goes there again volume heavy or light

0 · Reply

Dexter2025 Apr. 22 at 7:52 PM

$MDAI I’m in this big time and very bullish!!!!

0 · Reply

Dexter2025 Apr. 22 at 7:51 PM

$MDAI Okay all you kids in the back, listen up. Here’s the question: how many of you think FDA approval could be announced at the late May annual meeting. Raise your hands. Now, how many of you think it will be announced at the end of the 2nd quarter? Again, raise your hands. Finally, do any of you think that decision could be delayed past the end of June? I feel like we are close to the announcement, however, I’m not seeing enough volume yet indicating exactly how soon. Anyone have any better info speak up. Thanks and happy Earth Day!

2 · Reply

Jwex2012 Apr. 22 at 4:52 PM

$MDAI We need the FDA to step it up. That would get the volume going!!

0 · Reply

cryptopsych Apr. 22 at 3:13 PM

$MDAI tbh ppl don’t actually realise how much this company can make a difference to ppls lives via their AI outlook, it’s crazy, I’m not selling this anytime soon

0 · Reply

Milli80 Apr. 22 at 1:50 PM

$MDAI just needs volume 😭

0 · Reply

ChubbyDave Apr. 22 at 12:14 PM

$MDAI everyday that passes is only inching closer to the inevitable rocket fuel 🚀🚀🚀 to launch us to Saturn 🪐🪐🪐 in the mean time, we stay patient, keep buying… we’ll get our chance to laugh at the shorties soon…

1 · Reply

ImadogImaMut Apr. 22 at 11:50 AM

$MDAI Can you imagine being picked on by naked shorts as you have all the hope that comes perhaps leading a small biotech that has such promising IP. We have one of the first tangible incarnations of AI that deals with the nasty business of diabetic foot care . That’s the equivalent of an infinate TAM 😂

0 · Reply

Jimzi1 Apr. 21 at 6:52 PM

$MDAI think the BOD prefer Barda support than yours - they don’t fuck about with low volume TA

1 · Reply

Market Cap	57.28M
Revenue (ttm)	19.65M
Net Income (ttm)	-7.57M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-38.52%
Debt to Equity Ratio	-0.97

Volume	285,200
Avg Vol	777,138
Day's Range	N/A - N/A
Shares Out	31.82M
Stochastic %K	37%
Beta	0.91
Analysts	Strong Sell
Price Target	$4.67